Drugs / RCT-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02330146 | May 2015 → Dec 2016 | tendinosis | RepliCel Life Sciences, Inc. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RCT-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02330146 ↗ |
| Modality | Cell therapy | “Cultured, autologous hair follicle cells suspended in cryomedium” NCT02330146 ↗ |
| Route | Other | “ultrasound-guided injections” NCT02330146 ↗ |